Treatment for hypertension, female in Europe & Central Asia (excluding high income)
Europe & Central Asia (excluding high income): Treatment for hypertension, female was 58.8% in 2019. ▲ Rising
Treatment for hypertension, female in Europe & Central Asia (excluding high income), 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of female adults ages 30-79 with hypertension.
Analysis
Europe & Central Asia (excluding high income) recorded 58.8% for treatment for hypertension, female in 2019.
Compared with earlier readings it is down 0.4% on the previous year and up 0.4% over ten years.
Over the whole period, treatment for hypertension, female in Europe & Central Asia (excluding high income) peaked at 59.7% in 2013 and was at its lowest, 35.1%, in 1990.
That places Europe & Central Asia (excluding high income) 12th out of 43 groups with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, female in Europe & Central Asia (excluding high income), year by year
| Year | % of female adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 35.1% | — |
| 1991 | 36.4% | +3.5% |
| 1992 | 37.6% | +3.5% |
| 1993 | 38.9% | +3.5% |
| 1994 | 40.3% | +3.6% |
| 1995 | 41.7% | +3.3% |
| 1996 | 43.0% | +3.3% |
| 1997 | 44.4% | +3.2% |
| 1998 | 45.8% | +3.1% |
| 1999 | 47.1% | +2.9% |
| 2000 | 48.4% | +2.8% |
| 2001 | 49.8% | +2.8% |
| 2002 | 51.1% | +2.8% |
| 2003 | 52.5% | +2.6% |
| 2004 | 53.8% | +2.5% |
| 2005 | 55.1% | +2.3% |
| 2006 | 56.2% | +2.0% |
| 2007 | 57.1% | +1.7% |
| 2008 | 58.0% | +1.4% |
| 2009 | 58.6% | +1.0% |
| 2010 | 59.0% | +0.8% |
| 2011 | 59.4% | +0.6% |
| 2012 | 59.6% | +0.4% |
| 2013 | 59.7% | +0.1% |
| 2014 | 59.7% | -0.0% |
| 2015 | 59.6% | -0.2% |
| 2016 | 59.4% | -0.2% |
| 2017 | 59.2% | -0.4% |
| 2018 | 59.0% | -0.3% |
| 2019 | 58.8% | -0.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 41.0% | 35.1% | 47.1% | 10 |
| 2000s | 54.0% | 48.4% | 58.6% | 10 |
| 2010s | 59.3% | 58.8% | 59.7% | 10 |
Countries ranked near Europe & Central Asia (excluding high income)
More health data for Europe & Central Asia (excluding high income)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, male, annual growth rate 2.65 % change on previous year (2025)
- Population ages 45-49, female, per capita 0.0335 units per person (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 10-14, female, per capita 0.0381 units per person (2025)
- Population ages 45-49, female, annual growth rate 2.23 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0363 units per person (2025)
- Population ages 40-44, female, annual growth rate 1.72 % change on previous year (2025)
- Population ages 10-14, male, per unit of GDP 0 units per US$ of GDP (2025)
All data for Europe & Central Asia (excluding high income) →
Frequently asked questions
- What is treatment for hypertension, female in Europe & Central Asia (excluding high income)?
- Treatment for hypertension, female in Europe & Central Asia (excluding high income) was 58.8% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, female recorded in Europe & Central Asia (excluding high income)?
- The highest recorded value was 59.7% in 2013.
- What is the lowest treatment for hypertension, female recorded in Europe & Central Asia (excluding high income)?
- The lowest recorded value was 35.1% in 1990.
- How does Europe & Central Asia (excluding high income) rank for treatment for hypertension, female?
- Europe & Central Asia (excluding high income) ranks 12th out of 43 groups with data for 2019.
- Is treatment for hypertension, female rising or falling in Europe & Central Asia (excluding high income)?
- Over the last ten years it is up 0.4%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia (excluding high income) data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.